journal
https://read.qxmd.com/read/38747338/uncovering-the-wwtr1-ncoa2-gene-fusion-in-low-grade-myoepithelial-rich-neoplasm-with-hmga2-expression-a-case-report
#21
JOURNAL ARTICLE
Ziyad Alsugair, Daniel Pissaloux, Françoise Descotes, Franck Tirode, Jonathan Lopez, Jimmy Perrot, Ariane Lapierre, Maxime Fieux, Pierre Philouze, Anne Champagnac, Mihaela Onea, Nazim Benzerdjeb
We describe a case of a pleomorphic adenoma (PA) arising from the para-tracheal accessory salivary gland in a 44-year-old male harboring a novel WWTR1::NCOA2 gene fusion. To our knowledge, this novel gene fusion has not been described previously in salivary gland tumors. The patient presented with hoarseness of voice. The radiological exam revealed a mass in the upper third of the trachea involving the larynx. Histologically, the tumor consisted of bland-looking monocellular eosinophilic epithelial cells arranged in cords and sheets separated by thin fibrous stroma, focally forming a pseudo-tubular pattern...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38747337/exploration-of-poly-adp-ribose-polymerase-inhibitor-resistance-in-the-treatment-of-brca1-2-mutated-cancer
#22
REVIEW
Shuyi Wu, Xuanjie Yao, Weiwei Sun, Kaitao Jiang, Jie Hao
Breast cancer susceptibility 1/2 (BRCA1/2) genes play a crucial role in DNA damage repair, yet mutations in these genes increase the susceptibility to tumorigenesis. Exploiting the synthetic lethality mechanism between BRCA1/2 mutations and poly(ADP-ribose) polymerase (PARP) inhibition has led to the development and clinical approval of PARP inhibitor (PARPi), representing a milestone in targeted therapy for BRCA1/2 mutant tumors. This approach has paved the way for leveraging synthetic lethality in tumor treatment strategies...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38747331/metastasizing-aneurysmal-dermatofibroma-initially-diagnosed-as-angiosarcoma-confirmed-by-cd63-prkcd-fusion-gene-detection-with-nanopore-sequencing
#23
JOURNAL ARTICLE
Naoki Takeda, Naohiro Makise, Jason Lin, Hajime Kageyama, Mariko Oikawa, Takahiro Sugiyama, Hidetada Kawana, Akinobu Araki, Toshinori Tuskanishi, Hideyuki Kinoshita, Yoko Hagiwara, Hiroto Kamoda, Toru Motoi, Tsukasa Yonemoto, Masahito Kawazu, Makiko Itami
Dermatofibroma (DF) is a benign tumor that forms pedunculated lesions ranging in size from a few millimeters to 2 cm, usually affecting the extremities and trunks of young adults. Histopathologically, DF is characterized by the storiform proliferation of monomorphic fibroblast-like spindle cells. In addition to neoplastic cells, secondary elements such as foamy histiocytes, Touton-type giant cells, lymphoplasmacytes, and epidermal hyperplasia are characteristic histological features. Several histological variants, including atypical, cellular, aneurysmal, and lipidized variants, have been reported; cases with variant histologies are sometimes misdiagnosed as sarcomas...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38738968/constitutional-and-acquired-genetic-variants-in-arid5b-in-pediatric-b-cell-precursor-acute-lymphoblastic-leukemia
#24
JOURNAL ARTICLE
Charlotte Ragnarsson, Minjun Yang, Larissa Helena Moura-Castro, Efe Aydın, Rebeqa Gunnarsson, Linda Olsson-Arvidsson, Henrik Lilljebjörn, Thoas Fioretos, Nicolas Duployez, Marketa Zaliova, Jan Zuna, Anders Castor, Bertil Johansson, Kajsa Paulsson
Constitutional polymorphisms in ARID5B are associated with an increased risk of developing high hyperdiploid (HeH; 51-67 chromosomes) pediatric B-cell precursor acute lymphoblastic leukemia (BCP ALL). Here, we investigated constitutional and somatic ARID5B variants in 1335 BCP ALL cases from five different cohorts, with a particular focus on HeH cases. In 353 HeH ALL that were heterozygous for risk alleles and trisomic for chromosome 10, where ARID5B is located, a significantly higher proportion of risk allele duplication was seen for the SNPs rs7090445 (p = 0...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38738966/osteoblastoma-of-the-thumb-with-a-novel-prss44-alk-fusion-and-literature-review-of-osteoblastoma-of-hands-and-feet-bones
#25
REVIEW
Andrew I Brandea, Michelle Afkhami, Michael J Klein, Diana Bell
Osteoblastomas (OBs) are benign neoplasms constituting approximately 1% of primary bone tumors with a predilection for the spine and sacrum. We describe an OB of the proximal phalanx of the left thumb in a 38-year-old female. MRI of left hand demonstrated a 29-mm mildly expansile enhancing lesion involving the entire proximal phalanx of the first digit. Histology displayed a bone-forming tumor consisting of trabeculae of remodeled woven bone framed by plump osteoblasts in a vascularized background. Next-generation sequencing analysis identified a PRSS44::ALK fusion gene...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38722225/clinicopathologic-and-molecular-correlates-to-neoadjuvant-chemotherapy-induced-pathologic-response-in-breast-angiosarcoma
#26
JOURNAL ARTICLE
Hsin-Yi Chang, Josephine K Dermawan, Maria Gabriela Kuba, Aimee M Crago, Samuel Singer, William Tap, Ping Chi, Sandra D'Angelo, Evan Rosenbaum, Cristina R Antonescu
Both primary and secondary breast angiosarcoma (AS) are characterized by multifocal presentation and aggressive behavior. Despite multimodality therapy, local and distant relapse rates remain high. Therefore, neoadjuvant chemotherapy (NACT) is employed to improve the R0 resection rates and survival, but its benefits remain controversial. Herein, we investigate pathologic and molecular correlates to NACT-induced histologic response in a group of 29 breast AS, 4 primary and 25 radiation-associated (RA). The two NACT regimens applied were anthracycline- and non-anthracycline-based...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38722224/genomic-profiling-of-pleomorphic-rhabdomyosarcoma-reveals-a-genomic-signature-distinct-from-that-of-embryonal-rhabdomyosarcoma
#27
JOURNAL ARTICLE
Carla Saoud, Josephine K Dermawan, Aarti E Sharma, William Tap, Leonard H Wexler, Cristina R Antonescu
Pleomorphic rhabdomyosarcoma (PRMS) is a rare and highly aggressive sarcoma, occurring mostly in the deep soft tissues of middle-aged adults and showing a variable degree of skeletal muscle differentiation. The diagnosis is challenging as pathologic features overlap with embryonal rhabdomyosarcoma (ERMS), malignant Triton tumor, and other pleomorphic sarcomas. As recurrent genetic alterations underlying PRMS have not been described to date, ancillary molecular diagnostic testing is not useful in subclassification...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38722212/delineating-genotype-and-parent-of-origin-effect-on-the-phenotype-in-msh6-associated-lynch-syndrome
#28
JOURNAL ARTICLE
Anne-Sophie van der Werf-'t Lam, Mar Rodriguez-Girondo, Mandy Villasmil, Carli M Tops, Liselotte van Hest, Hans J P Gille, Floor A M Duijkers, Anja Wagner, Ellis Eikenboom, Tom G W Letteboer, Mirjam M de Jong, Sanne W Bajwa-Ten Broeke, Fonnet Bleeker, Encarna B Gomez Garcia, Mev Dominguez-Valentin, Pal Møller, Manon Suerink, Maartje Nielsen
BACKGROUND: This study investigates the potential influence of genotype and parent-of-origin effects (POE) on the clinical manifestations of Lynch syndrome (LS) within families carrying (likely) disease-causing MSH6 germline variants. PATIENTS AND METHODS: A cohort of 1615 MSH6 variant carriers (310 LS families) was analyzed. Participants were categorized based on RNA expression and parental inheritance of the variant. Hazard ratios (HRs) were calculated using weighted Cox regression, considering external information to address ascertainment bias...
May 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38656651/a-novel-t-x-21-p11-4-q22-12-translocation-adds-to-the-role-of-bcor-and-runx1-in-myelodysplastic-syndromes-and-acute-myeloid-leukemias
#29
JOURNAL ARTICLE
Elena Mavridou, Anair Graciela Lema Fernandez, Carlotta Nardelli, Valentina Pierini, Martina Quintini, Silvia Arniani, Danika Di Giacomo, Barbara Crescenzi, Caterina Matteucci, Constantina Sambani, Cristina Mecucci
In myeloid neoplasms, both fusion genes and gene mutations are well-established events identifying clinicopathological entities. In this study, we present a thus far undescribed t(X;21)(p11.4;q22.12) in five cases with myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML). The translocation was isolated or accompanied by additional changes. It did not generate any fusion gene or gene deregulation by aberrant juxtaposition with regulatory sequences. Molecular analysis by targeted next-generation sequencing showed that the translocation was accompanied by at least one somatic mutation in TET2, EZH2, RUNX1, ASXL1, SRSF2, ZRSR2, DNMT3A, and NRAS genes...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38656617/temporal-trends-and-regional-variability-in-braf-and-kras-genetic-testing-in-denmark-2010-2022-implications-for-precision-medicine
#30
JOURNAL ARTICLE
Matilde Grupe Frost, Kristoffer Jarlov Jensen, Espen Jimenez-Solem, Camilla Qvortrup, Tine Plato Kuhlmann, Jon Lykkegaard Andersen, Estrid Høgdall, Tonny Studsgaard Petersen
OBJECTIVE: This study aims to evaluate the developments in the testing of Kirsten Rat Sarcoma viral oncogene homolog (KRAS) and v-Raf murine sarcoma viral oncogene homolog B1 (BRAF) mutations across different cancer types and regions in Denmark from 2010 to 2022. STUDY DESIGN AND SETTING: Using comprehensive data from the Danish health registries, we linked molecular test results from the Danish Pathology Registry with cancer diagnoses from the Danish National Patient Registry between 2010 and 2022...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38656544/novel-mir143hg-plag1-gene-fusion-identified-in-a-rectal-myxoid-leiomyosarcoma
#31
JOURNAL ARTICLE
Shuanzeng Wei, Jianming Pei, Paul Belser, Teresa Lee, Jeffrey M Farma, Arthur S Patchefsky, Douglas B Flieder, Elizabeth A Montgomery
Myxoid leiomyosarcoma (MLS) is a rare but well-documented tumor that often portends a poor prognosis compared to the conventional leiomyosarcoma. This rare sarcoma has been reported in the uterus, external female genitalia, soft tissue, and other locations. However, a definite rectal MLS has not been reported. Recently five cases of MLS were reported to harbor PLAG1 fusions (TRPS1::PLAG1, RAD51B::PLAG1, and TRIM13::PLAG1). In this report, we present a case of rectal MLS with a novel MIR143HG::PLAG1 fusion detected by RNA next-generation sequencing...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38607297/roles-and-interactions-of-tumor-microenvironment-components-in-medulloblastoma-with-implications-for-novel-therapeutics
#32
REVIEW
Hanjie Yang, Min Li, Yuhao Deng, Huantao Wen, Minjie Luo, Wangming Zhang
Medulloblastomas, the most common malignant pediatric brain tumors, can be classified into the wingless, sonic hedgehog (SHH), group 3, and group 4 subgroups. Among them, the SHH subgroup with the TP53 mutation and group 3 generally present with the worst patient outcomes due to their high rates of recurrence and metastasis. A novel and effective treatment for refractory medulloblastomas is urgently needed. To date, the tumor microenvironment (TME) has been shown to influence tumor growth, recurrence, and metastasis through immunosuppression, angiogenesis, and chronic inflammation...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38607246/fgfr1-fusions-as-a-novel-molecular-driver-in-rhabdomyosarcoma
#33
JOURNAL ARTICLE
Henry de Traux De Wardin, Joanna Cyrta, Josephine K Dermawan, Delphine Guillemot, Daniel Orbach, Isabelle Aerts, Gaelle Pierron, Cristina R Antonescu
The wide application of RNA sequencing in clinical practice has allowed the discovery of novel fusion genes, which have contributed to a refined molecular classification of rhabdomyosarcoma (RMS). Most fusions in RMS result in aberrant transcription factors, such as PAX3/7::FOXO1 in alveolar RMS (ARMS) and fusions involving VGLL2 or NCOA2 in infantile spindle cell RMS. However, recurrent fusions driving oncogenic kinase activation have not been reported in RMS. Triggered by an index case of an unclassified RMS (overlapping features between ARMS and sclerosing RMS) with a novel FGFR1::ANK1 fusion, we reviewed our molecular files for cases harboring FGFR1-related fusions...
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38593281/adolescent-presentation-of-fgfr1-ebf2-gene-fusion-mesenchymal-tumor
#34
LETTER
Omar Jaber, Iyad Sultan
No abstract text is available yet for this article.
April 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38517106/spindle-cell-neoplasms-with-novel-ltk-fusion-expanding-the-spectrum-of-kinase-fusion-positive-soft-tissue-tumors
#35
JOURNAL ARTICLE
Maximus C F Yeung, Josephine K Dermawan, Anthony P Y Liu, Albert Y L Lam, Cristina R Antonescu, Tony W H Shek
AIMS: Kinase fusion-positive soft tissue tumors represent an emerging, molecularly defined group of mesenchymal tumors with a wide morphologic spectrum and diverse activating kinases. Here, we present two cases of soft tissue tumors with novel LTK fusions. METHODS AND RESULTS: Both cases presented as acral skin nodules (big toe and middle finger) in pediatric patients (17-year-old girl and 2-year-old boy). The tumors measured 2 and 3 cm in greatest dimension...
March 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38481055/genomic-profile-analysis-of-leiomyomas-with-bizarre-nuclei-and-fumarate-hydratase-deficient-leiomyomas-strengths-weaknesses-and-limitations-of-array-cgh-interpretation
#36
JOURNAL ARTICLE
Quitterie Fontanges, Paul Dubos, Tom Lesluyes, Yec'han Laizet, Valérie Velasco, Bárbara Meléndez, Nicky D'Haene, Esther Oliva, Robert H Young, Laetitia Mayeur, Flora Rebier, Mélissa Alamé, Claire Larmonier, Mojgan Devouassoux-Shisheboran, Laurent Arnould, Isabelle Soubeyran, Camille Chakiba, Anne Floquet, Guillaume Babin, Frédéric Guyon, Eliane Mery, Sophie Le Guellec, Jean-Christophe Noël, Sabrina Croce, Frédéric Chibon
A close relationship has been demonstrated between genomic complexity and clinical outcome in uterine smooth muscle tumors. We studied the genomic profiles by array-CGH of 28 fumarate hydratase deficient leiomyomas and 37 leiomyomas with bizarre nuclei (LMBN) from 64 patients. Follow-up was available for 46 patients (from three to 249 months, mean 87.3 months). All patients were alive without evidence of disease. For 51 array-CGH interpretable tumors the mean Genomic Index (GI) was 16.4 (median: 9...
March 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38459940/novel-med15-atf1-fusion-in-a-pediatric-melanoma-with-spitzoid-features-and-aggressive-presentation
#37
JOURNAL ARTICLE
Larissa V Furtado, Maria Cardenas, Teresa Santiago, Robert E Ruiz, Zonggao Shi, Alberto Pappo, Marija Kacar
Childhood melanoma is a rare and biologically heterogeneous pediatric malignancy. The differential diagnosis of pediatric melanoma is usually broad, including a wide variety of spindle cell or epithelioid neoplasms. Different molecular alterations affecting the MAPK and PI3K/AKT/mTOR pathways, tumor suppressor genes, and telomerase reactivation have been implicated in melanoma tumorigenesis and progression. Here, we report a novel MED15::ATF1 fusion in a pediatric melanoma with spitzoid features and an aggressive clinical course...
March 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38459936/clonal-origin-and-genomic-diversity-in-lynch-syndrome-associated-endometrial-cancer-with-multiple-synchronous-tumors-identification-of-the-pathogenicity-of-mlh1-p-l582h
#38
JOURNAL ARTICLE
Kotaro Takahashi, Nozomi Yachida, Ryo Tamura, Sosuke Adachi, Shuhei Kondo, Tatsuya Abé, Hajime Umezu, Hiromi Nyuzuki, Shujiro Okuda, Hirofumi Nakaoka, Kosuke Yoshihara
Lynch syndrome-associated endometrial cancer patients often present multiple synchronous tumors and this assessment can affect treatment strategies. We present a case of a 27-year-old woman with tumors in the uterine corpus, cervix, and ovaries who was diagnosed with endometrial cancer and exhibited cervical invasion and ovarian metastasis. Her family history suggested Lynch syndrome, and genetic testing identified a variant of uncertain significance, MLH1 p.L582H. We conducted immunohistochemical staining, microsatellite instability analysis, and Sanger sequencing for Lynch syndrome-associated cancers in three generations of the family and identified consistent MLH1 loss...
March 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38780072/single-nucleotide-polymorphism-array-and-fluorescence-in-situ-hybridization-analysis-to-decode-the-cytogenetic-profile-of-atypical-partial-hydatidiform-moles-diagnosed-by-short-tandem-repeat-polymorphism-analysis
#39
JOURNAL ARTICLE
Yoshiya Suzuki, Hirokazu Usui, Eri Katayama, Asuka Sato, Natsuko Nakamura, Emiri Nakada, Akiko Omoto, Jun Okayama, Mika Sato, Akiko Nagasawa, Akiko Hirosawa, Makio Shozu, Kaori Koga
Accurate diagnosis of partial hydatidiform moles (PHMs) is crucial for improving outcomes of gestational trophoblastic neoplasia. The use of short tandem repeat (STR) polymorphism analysis to distinguish between PHM and hydropic abortuses is instrumental; however, its diagnostic power has not been comprehensively assessed. Herein, we evaluated the diagnostic efficacy of STR in differentiating between PHM and hydropic abortus, thus providing an opportunity for early measurement of human chorionic gonadotropin for PHMs...
February 2024: Genes, Chromosomes & Cancer
https://read.qxmd.com/read/38682608/segregation-immunohistochemical-molecular-and-functional-analyses-classify-a-novel-missense-variant-in-fumarate-hydratase-fh-as-pathogenic
#40
JOURNAL ARTICLE
Lydia Ouchene, Blake Wilde, Fiona Chan-Pak-Choon, Jose Camacho Valenzuela, Fadi Brimo, Leora Witkowski, Heather Christofk, Celine Domecq, Lili Fu, Evan Weber, Brianna Lemieux Anglin, Elena Netchiporouk, William D Foulkes
Hereditary leiomyomatosis and renal cell cancer (HLRCC) is an autosomal dominant cancer predisposition syndrome characterized by cutaneous leiomyomas, uterine leiomyomas, and aggressive renal cancer. Germline variants in the fumarate hydratase (FH) gene predispose to HLRCC. Identifying germline pathogenic FH variants enables lifetime renal cancer screening and genetic testing for family members. In this report, we present a FH missense variant (c.1039T>C (p.S347P)), initially classified as a variant of uncertain significance...
February 2024: Genes, Chromosomes & Cancer
journal
journal
30437
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.